These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9143459)

  • 1. Parathyroid imaging with technetium-99m labelled cationic complexes: which tracer and which technique should be used?
    Lind P
    Eur J Nucl Med; 1997 Mar; 24(3):243-5. PubMed ID: 9143459
    [No Abstract]   [Full Text] [Related]  

  • 2. Radionuclide parathyroid imaging.
    O'Doherty MJ
    J Nucl Med; 1997 Jun; 38(6):840-1. PubMed ID: 9189126
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
    Giordano A; Meduri G
    Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
    Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
    Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
    Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
    Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
    Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
    Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed tc-99m sestamibi washout in graves' disease.
    Balan KK; Baltrop AH; Wishart GC
    Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
    Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
    Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
    Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
    Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huang Z; Lou C
    J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion imaging for parathyroid localization in primary hyperparathyroidism.
    Levine DS; Wiseman SM
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):353-63. PubMed ID: 20214517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
    Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
    Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.